Reproducibility and validity in the clinical diagnosis of the nonfamilial dysplastic nevus: work in progress.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3738183)

Published in Recent Results Cancer Res on January 01, 1986

Authors

G C Roush, J M Kirkwood, M Ernstoff, S J Somma, P H Duray, S N Klaus, K S Stenn, L J Titus, A B Lerner

Articles by these authors

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68

A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol (2001) 6.12

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95

The early clinical manifestations of Lyme disease. Ann Intern Med (1983) 5.73

Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study. J Clin Oncol (1996) 3.30

Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst (1996) 3.23

The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20

Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J Infect Dis (1988) 3.02

Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol (1983) 2.65

Chronic radiodermatitis following cardiac catheterization. Arch Dermatol (1996) 2.34

Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum (1988) 2.21

Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19

The histopathology of experimentally infected hamsters with the Lyme disease spirochete, Borrelia burgdorferi. Proc Soc Exp Biol Med (1986) 2.18

Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons. Lancet (1997) 2.09

Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. Ann Intern Med (1985) 2.04

Lyme arthritis. Spirochetes found in synovial microangiopathic lesions. Am J Pathol (1985) 2.03

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study. J Clin Oncol (1998) 1.94

On the etiology of vitiligo and gray hair. Am J Med (1971) 1.88

Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res (1995) 1.85

Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat Genet (1999) 1.84

Prevalence of Borrelia burgdorferi in white-footed mice and Ixodes dammini at Fort McCoy, Wis. J Clin Microbiol (1987) 1.82

Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res (1996) 1.78

Experimental infection of the hamster with Borrelia burgdorferi. Ann N Y Acad Sci (1988) 1.77

Interstitial hypertension in superficial metastatic melanomas in humans. Cancer Res (1991) 1.73

Regulation of tyrosinase in human melanocytes grown in culture. J Cell Biol (1983) 1.71

Social facilitation: a meta-analysis of 241 studies. Psychol Bull (1983) 1.66

Action of light on frog pigment cells in culture. Pigment Cell Res (1990) 1.66

Telogen skin contains an inhibitor of hair growth. Br J Dermatol (1990) 1.64

Ectodermal dysplasias associated with clefting: significance of scalp dermatitis. J Am Acad Dermatol (1992) 1.63

Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. J Am Acad Dermatol (1989) 1.59

Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A (1992) 1.58

Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene (2006) 1.53

A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52

Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol (1990) 1.51

High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma. J Natl Cancer Inst (1990) 1.51

Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res (2000) 1.50

Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study. Hum Pathol (1989) 1.48

Normal murine melanocytes in culture. In Vitro Cell Dev Biol (1987) 1.47

Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of Eastern Cooperative Oncology Group Trial E1690. J Clin Oncol (2002) 1.43

Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer. J Urol (1999) 1.41

Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol (1998) 1.40

Scd3--a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics (2001) 1.38

Human melanocytes cultured from nevi and melanomas. J Invest Dermatol (1986) 1.36

Association of cell surface receptors for melanotropin with the Golgi region in mouse melanoma cells. Proc Natl Acad Sci U S A (1976) 1.35

Regulation of melanocyte stimulating hormone action at the receptor level: discontinuous binding of hormone to synchronized mouse melanoma cells during the cell cycle. Proc Natl Acad Sci U S A (1974) 1.33

Infantile myofibromatosis. Evidence for an autosomal-dominant disorder. Am J Surg Pathol (1984) 1.32

5,6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature (1978) 1.31

Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am (1984) 1.30

SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas. Oncogene (2007) 1.29

NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells. Cancer Res (2000) 1.26

Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol (1982) 1.25

Construction of a representative cDNA library from prostatic intraepithelial neoplasia. Cancer Res (1996) 1.23

Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J Immunol Methods (1992) 1.22

Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest (1989) 1.22

The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration. Lab Invest (1989) 1.22

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys (1998) 1.22

Migrating epidermis produces AB2 collagen and requires continual collagen synthesis for movement. Nature (1979) 1.22

Interferons in the treatment of human cancer. J Clin Oncol (1984) 1.22

Vitiligo. What is it? Is it important? JAMA (1978) 1.21

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey. Vaccine (1997) 1.21

Trends in female breast cancer in Connecticut and the United States. J Clin Epidemiol (1991) 1.20

A mouse model for vitiligo. J Invest Dermatol (1986) 1.19

Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells. Proc Natl Acad Sci U S A (2000) 1.19

Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis (2000) 1.18

Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. J Immunother Emphasis Tumor Immunol (1996) 1.16

Aortic endothelial cell migration. I. Matrix requirements and composition. Am J Pathol (1982) 1.16

Adenocarcinoid (mucinous carcinoid) of the appendix. Gastroenterology (1984) 1.15

Patient preferences for adjuvant interferon alfa-2b treatment. J Clin Oncol (2001) 1.14

Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med (1985) 1.13

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13

Langerhans cell histiocytosis of the female genital tract. Cancer (1991) 1.13

Epibolin: a protein of human plasma that supports epithelial cell movement. Proc Natl Acad Sci U S A (1981) 1.12

Mechanism of bovine prothrombin activation by an insoluble preparation of bovine factor X a (thrombokinase). Biochemistry (1972) 1.12

Sinonasal cancer and occupation: a case-control study. Am J Epidemiol (1980) 1.12

Cutis laxa associated with pulmonary artery stenosis. J Pediatr (1968) 1.11

The effects of ultraviolet light and certain drugs on La-bearing Langerhans cells in murine epidermis. Cell Immunol (1981) 1.11

Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res (1997) 1.10

The surgical pathology of human Lyme disease. An enlarging picture. Am J Surg Pathol (1987) 1.10

Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma. Oncologist (2000) 1.09

Transplantation of human melanocytes. J Invest Dermatol (1987) 1.09

Multiple mechanisms of dissociated epidermal cell spreading. J Cell Biol (1983) 1.09

Cutaneous toxicity of bleomycin therapy. Arch Dermatol (1973) 1.08

Tyrosinases of murine melanocytes with mutations at the albino locus. Proc Natl Acad Sci U S A (1988) 1.08

Comparison of toxicity and survival following intraperitoneal recombinant interleukin-2 for persistent ovarian cancer after platinum: twenty-four-hour versus 7-day infusion. J Clin Oncol (1997) 1.08

Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol (1996) 1.07

Tyrosinase activity and abundance in Cloudman melanoma cells. Arch Biochem Biophys (1984) 1.07

Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay. Biochem Biophys Res Commun (2000) 1.06

Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. Hum Reprod (2013) 1.06

Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res (1996) 1.06

Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer (1996) 1.05

Borrelia burgdorferi myositis: report of eight patients. J Neurol (1993) 1.05

Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virus. Am J Clin Pathol (1998) 1.05

The effect of vitiligo on sexual relationships. J Am Acad Dermatol (1990) 1.03

Borrelia burgdorferi and Ixodes dammini prevalent in the greater Philadelphia area. J Infect Dis (1990) 1.03